• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    38.14 0.00(0.00%) 4:00PM EST
    |After Hours : 38.14 0.00 (0.00%) 4:47PM EST
    Add to Portfolio
    Prev Close:38.14
    Open:37.88
    Bid:38.04 x 200
    Ask:38.23 x 100
    1y Target Est:45.89
    Beta:2.83
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:37.26 - 38.27
    52wk Range:15.64 - 38.54
    Volume:1,167,618
    Avg Vol (3m):1,323,460
    Market Cap:3.82B
    P/E (ttm):N/A
    EPS (ttm):-0.95
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACAD 0.00%3.82B
    AZNDown 0.72%85.62B
    LLYUp 0.40%74.93B
    PFEUp 0.23%212.30B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31,837.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.93
    Quarterly EPS Est (Mar-15) :-0.27
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-2.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback